Financial Gravity Asset Management, Inc. Catalent, Inc. Transaction History

Financial Gravity Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 26, 2024	BUY	$32.18 - $46.57 $128 - $186	4 New	4 $160,000
Q3 2023 Nov 15, 2023	SELL	$44.2 - $50.2 $1,723 - $1,957	-39 Reduced 90.7%	4 $0
Q2 2023 Aug 08, 2023	SELL	$31.86 - $67.26 $732 - $1,546	-23 Reduced 34.85%	43 $280,000
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $954 - $1,559	21 Added 46.67%	66 $234,000
Q4 2022 Feb 15, 2023	SELL	$41.39 - $81.0 $7,077 - $13,851	-171 Reduced 79.17%	45 $302,000
Q3 2022 Nov 03, 2022	BUY	$72.36 - $113.1 $15,629 - $24,429	216 New	216 $258,000
Q4 2019 Feb 28, 2020	SELL	$47.06 - $56.64 $16,471 - $19,824	-350 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$47.45 - $58.05 $6,215 - $7,604	131 Added 59.82%	350 $17,000
Q2 2019 Jul 26, 2019	SELL	$39.26 - $54.21 $36,354 - $50,198	-926 Reduced 80.87%	219 $12,000
Q1 2019 Apr 19, 2019	BUY	$29.84 - $43.92 $358 - $527	12 Added 1.06%	1,145 $47,000
Q3 2018 Oct 31, 2018	BUY	$40.12 - $45.55 $45,455 - $51,608	1,133 New	1,133 $43,000

319

114M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.